These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 2509709)
41. Different effects of two aldose reductase inhibitors on nociception and prostaglandin E. Calcutt NA; Li L; Yaksh TL; Malmberg AB Eur J Pharmacol; 1995 Oct; 285(2):189-97. PubMed ID: 8566138 [TBL] [Abstract][Full Text] [Related]
42. Comparison of aldose reductase inhibitors by determination of IC50 with bovine and rat lens extracts. Müller P; Hockwin O; Ohrloff C Ophthalmic Res; 1985; 17(2):115-9. PubMed ID: 3920598 [TBL] [Abstract][Full Text] [Related]
43. Aminoguanidine does not inhibit aldose reductase activity in galactose-fed rats. Dvornik D; Hohman TC; Basso MD J Diabetes Complications; 1996; 10(1):23-30. PubMed ID: 8639971 [TBL] [Abstract][Full Text] [Related]
44. [Diabetic changes in pupillary reaction and iridal pathology. No. 1. The role of aldose reductase to the delayed pupillary reaction in galactose-fed rats]. Terubayashi H; Akagi Y; Kador PF; Kinoshita JH Nippon Ganka Gakkai Zasshi; 1988 Mar; 92(3):484-8. PubMed ID: 3137794 [No Abstract] [Full Text] [Related]
46. In vitro inhibition of glucose phosphorylation by an aldose-reductase inhibitor (Tolrestat) in some non-insulin-sensitive rabbit tissues. Iannello S; Cavaleri A; Camuto M; Belfiore F J Diabetes Complications; 1999; 13(2):68-73. PubMed ID: 10432169 [TBL] [Abstract][Full Text] [Related]
47. Pathogenesis of diabetic neuropathy--do hyperglycemia and aldose reductase inhibitors affect neuroactive steroid formation in the rat sciatic nerves? Colciago A; Negri-Cesi P; Celotti F Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):22-6. PubMed ID: 11835121 [TBL] [Abstract][Full Text] [Related]
48. Synthesis and aldose reductase-inhibitory activities of structural analogues of WF-3681, a novel aldose reductase inhibitor. Namiki T; Baba Y; Suzuki Y; Nishikawa M; Sawada K; Itoh Y; Oku T; Kitaura Y; Hashimoto M Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1404-14. PubMed ID: 3138031 [No Abstract] [Full Text] [Related]
49. Inhibition of aldose reductase from rat nervous tissue by metabolites of cyclandelate. Van den Hoven WE; Hall DW; Burns JW Br J Clin Pract Suppl; 1984; 34():31-3. PubMed ID: 6430320 [No Abstract] [Full Text] [Related]
57. Aldose reductase inhibitors and prevention of galactose cataracts in rats. Unakar N; Tsui J; Johnson M Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646 [TBL] [Abstract][Full Text] [Related]
58. Inhibition of aldose reductases from rat and bovine lenses by flavonoids. Okuda J; Miwa I; Inagaki K; Horie T; Nakayama M Biochem Pharmacol; 1982 Dec; 31(23):3807-22. PubMed ID: 6818971 [TBL] [Abstract][Full Text] [Related]
59. Effect of aldose reductase inhibitor ONO 2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats. Yoshida T; Nishioka H; Yoshioka K; Nakano K; Kondo M; Terashima H Diabetes; 1987 Jan; 36(1):6-13. PubMed ID: 3025043 [TBL] [Abstract][Full Text] [Related]
60. Isoliquiritigenin: a new aldose reductase inhibitor from glycyrrhizae radix. Aida K; Tawata M; Shindo H; Onaya T; Sasaki H; Yamaguchi T; Chin M; Mitsuhashi H Planta Med; 1990 Jun; 56(3):254-8. PubMed ID: 2118267 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]